skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 88  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: Taylor & Francis Open Access remove PubMed Central remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries
Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries
Material Type:
Article 		Add to My Research

Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries

Emerging microbes & infections, 2018-03, Vol.7 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2018 2018 ;Copyright Nature Publishing Group Mar 2018 ;The Author(s) 2018. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1038/s41426-018-0038-9 ;PMID: 29535298

Full text available

Citations Cited by
2
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
Material Type:
Article 		Add to My Research

On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review

Global health action, 2018, Vol.11 (1), p.1447828-14 [Peer Reviewed Journal]

2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;Copyright Taylor & Francis Ltd. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2018.1447828 ;PMID: 29564962

Full text available

Citations Cited by
3
Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study
Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study
Material Type:
Article 		Add to My Research

Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study

Clinical epidemiology, 2019-01, Vol.11, p.197-205 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Hawley et al. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/clep.s176723 ;PMID: 30881136

Full text available

Citations Cited by
4
Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses
Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses
Material Type:
Article 		Add to My Research

Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

Infection and drug resistance, 2019-07, Vol.12, p.2311-2322 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Liu et al. 2019 Liu et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S207809 ;PMID: 31440067

Full text available

Citations Cited by
5
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool
Material Type:
Article 		Add to My Research

Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool

Global health action, 2012-01, Vol.5 (1), p.1-8 [Peer Reviewed Journal]

2012 Peter Byasset al. 2012 ;2012 Peter Byass et al. 2012 ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.3402/gha.v5i0.19281 ;PMID: 22944365

Full text available

Citations Cited by
6
Systematic review of pharmacoeconomic models for schizophrenia
Systematic review of pharmacoeconomic models for schizophrenia
Material Type:
Article 		Add to My Research

Systematic review of pharmacoeconomic models for schizophrenia

Journal of market access & health policy, 2018, Vol.6 (1), p.1508272-10 [Peer Reviewed Journal]

2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;Copyright Taylor & Francis Ltd. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 2001-6689 ;EISSN: 2001-6689 ;DOI: 10.1080/20016689.2018.1508272 ;PMID: 30128087

Full text available

Citations Cited by
7
The option value of government guarantees in infrastructure projects
The option value of government guarantees in infrastructure projects
Material Type:
Article 		Add to My Research

The option value of government guarantees in infrastructure projects

Construction Management and Economics, 2008-11, Vol.26 (11), p.1171-1180 [Peer Reviewed Journal]

ISSN: 0144-6193 ;EISSN: 1568-5551 ;DOI: 10.1080/01446190802428051

Digital Resources/Online E-Resources

Citations Cited by
8
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
Material Type:
Article 		Add to My Research

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study

International journal of chronic obstructive pulmonary disease, 2022-11, Vol.17, p.2987-3000 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 de Nigris et al. 2022 de Nigris et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S381138

Full text available

Citations Cited by
9
Loss functions in restricted parameter spaces and their Bayesian applications
Loss functions in restricted parameter spaces and their Bayesian applications
Material Type:
Article 		Add to My Research

Loss functions in restricted parameter spaces and their Bayesian applications

Journal of applied statistics, 2019-10, Vol.46 (13), p.2314-2337 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2019 ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2019 The Author(s) ;ISSN: 0266-4763 ;EISSN: 1360-0532 ;DOI: 10.1080/02664763.2019.1586848 ;PMID: 32256183

Digital Resources/Online E-Resources

Citations Cited by
10
Application of a hybrid model in predicting the incidence of tuberculosis in a Chinese population
Application of a hybrid model in predicting the incidence of tuberculosis in a Chinese population
Material Type:
Article 		Add to My Research

Application of a hybrid model in predicting the incidence of tuberculosis in a Chinese population

Infection and drug resistance, 2019-04, Vol.12, p.1011-1020 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Li et al. 2019 Li et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S190418 ;PMID: 31118707

Full text available

Citations Cited by
11
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
Material Type:
Article 		Add to My Research

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models

Journal of market access & health policy, 2021, Vol.9 (1), p.2002006-2002006 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) ;ISSN: 2001-6689 ;EISSN: 2001-6689 ;DOI: 10.1080/20016689.2021.2002006 ;PMID: 34790341

Full text available

Citations Cited by
12
A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia
A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia
Material Type:
Article 		Add to My Research

A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia

Clinical ophthalmology (Auckland, N.Z.), 2022-08, Vol.16, p.2403-2412 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Bala et al. 2022 Bala et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S370420 ;PMID: 35942082

Full text available

Citations Cited by
13
Comprehensive Custom-Pak ® in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis
Comprehensive Custom-Pak ® in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis
Material Type:
Article 		Add to My Research

Comprehensive Custom-Pak ® in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis

ClinicoEconomics and outcomes research, 2023-03, Vol.15, p.151-164 [Peer Reviewed Journal]

2023 Punch et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Punch et al. 2023 Punch et al. ;ISSN: 1178-6981 ;EISSN: 1178-6981 ;DOI: 10.2147/CEOR.S397671 ;PMID: 36883115

Full text available

Citations Cited by
14
The Cost of Neurodevelopmental Disability: Scoping Review of Economic Evaluation Methods
The Cost of Neurodevelopmental Disability: Scoping Review of Economic Evaluation Methods
Material Type:
Article 		Add to My Research

The Cost of Neurodevelopmental Disability: Scoping Review of Economic Evaluation Methods

ClinicoEconomics and outcomes research, 2022-01, Vol.14, p.665-682 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Kularatna et al. 2022 Kularatna et al. ;ISSN: 1178-6981 ;EISSN: 1178-6981 ;DOI: 10.2147/CEOR.S370311

Full text available

Citations Cited by
15
The Role of Agriculture and Foreign Remittances in Mitigating Rural Poverty: Empirical Evidence from Pakistan
The Role of Agriculture and Foreign Remittances in Mitigating Rural Poverty: Empirical Evidence from Pakistan
Material Type:
Article 		Add to My Research

The Role of Agriculture and Foreign Remittances in Mitigating Rural Poverty: Empirical Evidence from Pakistan

Risk management and healthcare policy, 2020-01, Vol.13, p.13-26 [Peer Reviewed Journal]

2020 Liu et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Liu et al. 2020 Liu et al. ;ISSN: 1179-1594 ;EISSN: 1179-1594 ;DOI: 10.2147/RMHP.S235580 ;PMID: 32021516

Full text available

Citations Cited by
16
Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
Material Type:
Article 		Add to My Research

Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations

ClinicoEconomics and outcomes research, 2022-01, Vol.14, p.499-511 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Ronquest et al. 2022 Ronquest et al. ;ISSN: 1178-6981 ;EISSN: 1178-6981 ;DOI: 10.2147/CEOR.S359025 ;PMID: 35923520

Full text available

Citations Cited by
17
Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research
Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research
Material Type:
Article 		Add to My Research

Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research

Clinical epidemiology, 2018-01, Vol.10, p.1773-1786 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Toh et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S178163 ;PMID: 30568510

Full text available

Citations Cited by
18
A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer's Perspective
A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer's Perspective
Material Type:
Article 		Add to My Research

A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer's Perspective

Diabetes, metabolic syndrome and obesity, 2021-01, Vol.14, p.3147-3160 [Peer Reviewed Journal]

2021 Nuijten et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Nuijten et al. 2021 Nuijten et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S284855 ;PMID: 34267531

Full text available

Citations Cited by
19
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
Material Type:
Article 		Add to My Research

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.657-666 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Gadler et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-6981 ;EISSN: 1178-6981 ;DOI: 10.2147/CEOR.S114921 ;PMID: 27826203

Full text available

Citations Cited by
20
Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]
Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]
Material Type:
Article 		Add to My Research

Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

International journal of general medicine, 2022-01, Vol.15, p.8055-8061 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Boehringer Ingelheim International GmbH. 2022 Boehringer Ingelheim International GmbH. ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S391712

Full text available

Citations Cited by

Results 1 - 20 of 88  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2007  (7)
  2. 2007 To 2011  (6)
  3. 2012 To 2014  (18)
  4. 2015 To 2018  (28)
  5. After 2018  (30)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait